Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics;Návrh antitrombotické profylaxe a péče o trombofilní stavy v gynekologii a porodnictví

Vnitrni Lekarstvi

Volumn 52, Issue SUPPL. 1, 2006, Pages 58-62

  Dulíček, Petr ^a   Penka, M ^b   Binder, T ^c   Unzeitig, V ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Obstetrics complications; Prophylaxis; Thrombophilia; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; PREGNANCY; PROPHYLAXIS; PUERPERIUM; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PUERPERAL DISORDERS; PULMONARY EMBOLISM; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33645463236     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bates SM, Greer IA, Hirsh J et al. Use of antithrombotic agents during pregnancy. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 627-644.
2. Bick RL. Recurrent miscarriage syndrome due to Blood Coagulation Protein/platelet defects: Prevalence, Treatment and Outcomes Results. Clin Appl Thromb Hemost 2000; 6: 115-125.
3. Binder T. Prevence tromboembolické nemoci v tě hotenství. Komentář. Gynekologie po promoci 2005; 1: 8-11.
4. Brenner B. Inherited thrombophilia and fetal loss. Curr Opin Hematol 2000; 7: 290-295.
5. Gerhardt A, Sharf RE, Beckmann MW et al. Prothrombin and factor V mutations in women with history of thrombosis during pregnancy and the puerperium. N Engl J of Med 2000; 342: 374-380.
6. Greer IA. Epidemiology, risk factors and prophylaxis of venous thromboembolism in obstetrics and gynaecology. Clinics in Obstetrics and Gynaecology 1997; 11: 403-430.
7. Greer IA. Thrombosis in pregnancy: maternal ad fetal issues. Lancet 1999; 353: 1258-1265.
8. Greer IA. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000; 342: 424-425.
9. Greer I, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thrombembolism in pregnancy: a systematic review of safety and efficacy. Review article. Blood 2005; 106: 401-407.
10. Hirsh J. Antithrombotic therapy during pregnancy. Guidelines for Antithrombotic Therapy. 5. ed. London: BC Decker Inc Hamilton 2005: 90-94.
11. Janků K, Penka M. Gravidita při trvalé antikoagulační léčbě. Kardio 1988; 14: 46-51.
12. Janků K, Penka M. Hyperkoagulační syndrom v těhotenství na podkladě defektu antitrombinu III. Čes Gynek 1990; 55: 657-659.
13. Kvasnička J, Srp B. Doporučení k prevenci a léčbě poruch hemostázy v těhotenství a šestinedělí. Čes Gynek 1991; 56: 302-307.
14. Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997; 104: 191-197
15. Pabinger I, Grafenhofer H, Kyrle PA et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous tromboembolism. Blood 2002; 100: 1060-1062.
16. Penka M, Janků K, Hrčková V. Hyperkoagulač ní stavy v těhotenství. Prakt Lék 1986; 66: 333-335.
17. Rai R, Regan L. Thrombophilia and adverse pregnancy outcome. Semin Reprod Med 2000; 18: 369-377.
18. Simioni P, Tormene D, Prandoni P et al. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism. Thromb Haemost 2001; 86: 929.
19. Srp B, Malý J, Turek P et al. K otázce prevence, diagnostiky a léčby trombembolických komplikací a diseminované intravaskulární koagulace v porodnictví. Čes Gynek 1994; 59: 268-269.